This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_PROSTATE_EXALLC for full statistics.
This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_PROSTATE_EXALLC for full statistics.
CD2_INSITU_PROSTATE
Grade III Prostatic Intraepithelial Neoplasia: High grade prostatic intraepithelial neoplasia characterized by the presence of severe architectural and cytologic abnormalities.
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
429209 |
1. Apply sex-specific ruleonly males |
189303 |
2. Check conditions
|
173618 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
137 |
4. Check minimum number of eventsNone |
137 |
5. Include endpointsNone |
137 |
6. Filter based on genotype QC (FinnGen only) |
135 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
List of similar endpoints to Carcinoma in situ of prostate based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
All | Female | Male | |
---|---|---|---|
Number of individuals | 135 | - | 135 |
Unadjusted period prevalence (%) | 0.07 | - | 0.07 |
Median age at first event (years) | 67.53 | - | 67.53 |
Not a core endpoint, no data to show.
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Index endpoint: CD2_INSITU_PROSTATE – Carcinoma in situ of prostate
GWS hits: -
Loading Relationships table